Impact BioMedical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSEAM:IBO Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
27 Mar 26	SellUS$25,330	Todd Macko	Individual		45,000	US$0.60
23 Mar 26	SellUS$32,505	Jason Grady	Individual		50,000	US$0.65

Insider Trading Volume

Insider Buying: IBO insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of IBO?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	3,000,779	2.78%
Institutions	3,722,257	3.45%
General Public	7,765,797	7.2%
Public Companies	93,332,398	86.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 792.2%.

Top Shareholders

Top 25 shareholders own 92.8% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
86.2%	DSS, Inc.	92,980,843	US$52.0m	17,000%	no data
1.11%	Geode Capital Management, LLC	1,192,925	US$667.7k	1,500%	no data
0.66%	Vanguard Capital Management, LLC	708,168	US$396.4k	0%	no data
0.56%	State Street Global Advisors, Inc.	607,897	US$340.2k	5,050%	no data
0.54%	Vanguard Fiduciary Trust Company	585,198	US$327.5k	117%	no data
0.46%	Frank Heuszel	495,475	US$277.3k	419%	no data
0.33%	Alset Inc.	351,555	US$196.8k	0%	no data
0.28%	Heng Fai Chan	300,000	US$167.9k	0%	no data
0.28%	Mark Suseck	300,000	US$167.9k	0%	no data
0.28%	Elise Brownell	300,000	US$167.9k	0%	no data
0.28%	Christian Zimmerman	300,000	US$167.9k	0%	no data
0.28%	David Keene	300,000	US$167.9k	0%	no data
0.28%	Castel Hibbert	300,000	US$167.9k	0%	no data
0.28%	Melissa Sims	300,000	US$167.9k	0%	no data
0.24%	BlackRock, Inc.	259,946	US$145.5k	0%	no data
0.23%	Jason Grady	250,182	US$140.0k	137,000%	no data
0.23%	Northern Trust Global Investments	243,943	US$136.5k	2,290%	no data
0.14%	Todd Macko	155,122	US$86.8k	127,000%	no data
0.035%	Two Sigma Investments, LP	37,427	US$20.9k	-6.03%	no data
0.03%	UBS Asset Management AG	32,417	US$18.1k	1,390%	no data
0.03%	Vanguard Global Advisers, LLC	32,201	US$18.0k	0%	no data
0.0093%	Mason & Associates, Inc.	10,000	US$5.6k	0%	no data
0.0086%	Morgan Stanley	9,266	US$5.2k	0%	no data
0.0017%	Global Trust Asset Management, LLC	1,818	US$1.0k	0%	no data
0.00033%	Citigroup Inc.	353	US$199.1	35,200%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/09 10:07
End of Day Share Price	2026/06/09 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Impact BioMedical Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.